Ramasamy Paulmurugan, PhD and Tarik Massoud, MD, PhD Publish Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies

Ramasamy Paulmurugan, PhD

Tarik F. Massoud, MD, PhD

July 14th, 2021

The Department of Radiology is pleased to announce that Ramasamy Paulmurugan, PhD, associate professor of radiology in the Division of the Molecular Imaging Program at Stanford, and Tarik F. Massoud, MD, PhD, professor of radiology in the Division of Neuroimaging and Neurointervention, have published Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies, Volume 15 .

From the book description: Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies brings current knowledge from an international team of experts on the science and clinical management of glioblastoma chemoresistance. Glioblastoma (GBM) is the most invasive and malignant primary brain tumor in humans with poor survival after diagnosis, therefore it is imperative that molecular and cellular mechanisms behind therapy resistant GBM cells, as well as the therapeutic strategies available to counter the resistance are understood comprehensively.

Learn more here.